Data on Investigational Orexin-2 Receptor Agonist for Narcolepsy
Alkermes will present new data on ALKS 2680, an investigational orexin-2 receptor agonist for narcolepsy, at World Sleep Congress.
Source: sleepreviewmag.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Brian Raymer. Real-time updates on events, politics, business and more.